1. Home
  2. LCII vs ADPT Comparison

LCII vs ADPT Comparison

Compare LCII & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LCII

LCI Industries

HOLD

Current Price

$126.76

Market Cap

3.0B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$16.70

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCII
ADPT
Founded
1956
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
LCII
ADPT
Price
$126.76
$16.70
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$102.40
$16.60
AVG Volume (30 Days)
230.4K
2.5M
Earning Date
02-10-2026
02-10-2026
Dividend Yield
3.64%
N/A
EPS Growth
38.80
N/A
EPS
7.12
N/A
Revenue
$3,992,455,000.00
$252,754,000.00
Revenue This Year
$10.93
$50.81
Revenue Next Year
$4.29
$1.17
P/E Ratio
$17.75
N/A
Revenue Growth
5.74
42.57
52 Week Low
$72.31
$5.98
52 Week High
$126.56
$20.76

Technical Indicators

Market Signals
Indicator
LCII
ADPT
Relative Strength Index (RSI) 73.52 52.58
Support Level $122.53 $15.31
Resistance Level $125.00 $16.82
Average True Range (ATR) 2.45 0.72
MACD -0.24 -0.02
Stochastic Oscillator 95.59 62.33

Price Performance

Historical Comparison
LCII
ADPT

About LCII LCI Industries

LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: